The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.